MDMA is commonly known as Molly, XTC or Ecstasy (E). It’s scientific name is 3,4-Methylenedioxy-methamphetamine. MDMA is derived from naturally-occurring chemicals found in specific trees – Sassafras Albidum, or Ocotea Pretiosa. It is a psychoactive drug, primarily used as a recreational drug. The desired effects include altered sensations, increased energy, empathy, and pleasure. When taken by mouth, effects begin in 30 to 60 minutes and last 3 to 6 hours.
It belongs to a class of therapeutic /psychoactive drugs known as Empathogens. The term empathogen means “generating a state of empathy”. They produce experiences of emotional communion, oneness, relatedness, emotional openness—that is, empathy or sympathy—as particularly observed and reported for experiences with MDMA. It is also considered an Euphoric Stimulant.
Some of the desired short-term psychoactive effects of MDMA include:
-Euphoria – a sense of general well-being and happiness
-Increased self-confidence, sociability, and perception of facilitated communication
-Entactogenic effects—increased empathy or feelings of closeness with others and oneself
-Relaxation and reduced anxiety
-A sense of inner peace
-Enhanced sensation, perception, or sexuality
-Altered sense of time
Adverse effects include addiction, memory problems, paranoia, difficulty sleeping, teeth grinding, blurred vision, sweating, and a rapid heartbeat. Deaths have been reported due to increased body temperature and dehydration. Following use people often feel depressed and tired. MDMA acts primarily by increasing the activity of the neurotransmitters serotonin, dopamine, and noradrenaline in parts of the brain.
When taking Molly make sure you are in a safe, cool and positive environment.
Stay well hydrated, avoid alcohol and keep cool.
Don’t drink too much water, some people will forget to pee, or think that it is not important.
1-2 cups of Gatorade is great.
BE HAPPY. Feel physically and emotionally well, and happy in yourself.
Researchers are investigating whether MDMA may assist in treating severe, treatment-resistant posttraumatic stress disorder (PTSD). In 2017, the FDA granted MDMA a breakthrough therapy designation for PTSD, meaning that if studies show promise, a review for potential medical use could occur more quickly. MDMA is currently in clinical trials as a possible treatment aid for PTSD and anxiety in terminally ill patients, and for social anxiety in autistic adults.
MDMA was first developed in 1912 by Merck. It was used to enhance psychotherapy beginning in the 1970’s and became popular as a street drug in the 1980’s. MDMA was initially popular in the nightclub scene and at all-night dance parties (“raves”), but the drug now affects a broader range of people who more commonly call the drug Molly or XTC or Ecstasy.
“Young Adults” between the ages of 18 and 25 make up the largest percentage of current ecstasy users.
An estimated 20% of young adults reported using ecstasy at least once in their lifetime.
About 7% reported using the drug in the previous year.
In 2018, about 25 million people between the ages of 15 and 64 used ecstasy (0.3% of the world population). This was broadly similar to the percentage of people who use cocaine or amphetamines, but lower than for cannabis or opioids. In the United States, as of 2018, about 8% of people have used MDMA at some point in their lives and about 1.0% have used it in the last year.